BBIO vs IONS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

BBIO

32.9
AI Score
VS
IONS Wins

IONS

49.9
AI Score

Investment Advisor Scores

BBIO

33score
Recommendation
SELL

IONS

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BBIO IONS Winner
Revenue 791.36M 756.76M BBIO
Net Income -372.97M -317.14M IONS
Net Margin -47.1% -41.9% IONS
Operating Income -224.67M -350.42M BBIO
ROE 22.4% -80.6% BBIO
ROA -17.3% -10.9% IONS
Total Assets 2.16B 2.91B IONS
Cash 1.53B 296.30M BBIO
Current Ratio 2.09 5.43 IONS
Free Cash Flow -313.35M -457.26M BBIO

Relative Price Performance (Last 90 Days)

BBIO 1M: +20.4% · 3M: -2.1% IONS 1M: -36.0% · 3M: -52.3%

Current Technical Phase

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $78.17

IONS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.8%), weak momentum, RSI 17

RSI (14): 17.3 · Price: $27.31

Fundamentals Snapshot

Metric BBIO IONS
Market Cap — —
Forward P/E -286.0 -19.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 1.9% 0.5%
Gross Margin 0.9% 0.0%
Operating Margin -0.4% -0.6%
EPS -3.07 -3.35
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IONS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.